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Summary
Objective—Epilepsy surgery is the most effective treatment for select patients with drugresistant epilepsy. In this article, we aim to provide an accurate understanding of the current
epidemiologic characteristics of this intervention, as this knowledge is critical for guiding
educational, academic, and resource priorities.
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Methods—We profile the practice of epilepsy surgery between 1991 and 2011 in nine major
epilepsy surgery centers in the United States, Germany, and Australia. Clinical, imaging, surgical,
and histopathologic data were derived from the surgical databases at various centers.
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Results—Although five of the centers performed their highest number of surgeries for mesial
temporal sclerosis (MTS) in 1991, and three had their highest number of MTS surgeries in 2001,
only one center achieved its peak number of MTS surgeries in 2011. The most productive year for
MTS surgeries varied then by center; overall, the nine centers surveyed performed 48% (95%
confidence interval [CI] −27.3% to −67.4%) fewer such surgeries in 2011 compared to either 1991
or 2001, whichever was higher. There was a parallel increase in the performance of surgery for
nonlesional epilepsy. Further analysis of 5/9 centers showed a yearly increase of 0.6 ± 0.07% in
the performance of invasive electroencephalography (EEG) without subsequent resections.
Overall, although MTS was the main surgical substrate in 1991 and 2001 (proportion of total
surgeries in study centers ranging from 33.3% to 70.2%); it occupied only 33.6% of all resections
in 2011 in the context of an overall stable total surgical volume.
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Significance—These findings highlight the major aspects of the evolution of epilepsy surgery
across the past two decades in a sample of well-established epilepsy surgery centers, and the
critical current challenges of this treatment option in addressing complex epilepsy cases requiring
detailed evaluations. Possible causes and implications of these findings are discussed.
Keywords
Epilepsy surgery; Mesial temporal sclerosis; Neocortical epilepsy; Invasive EEG
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Mesial temporal lobe epilepsy (m-TLE) has traditionally been equated with the prototype of
drug-resistant focal epilepsy. When a randomized clinical trial compared surgical to medical
therapy for drug-resistant seizures, patients with TLE were the chosen study subjects.1
Major epilepsy advocacy groups declare TLE as the most common form of localizationrelated epilepsy.2 The bulk of epilepsy research funding focuses around TLE in general, and
m-TLE in particular.3 Against this landscape dominated by a perception of TLE as the
central driver of the drug-resistant epilepsy burden, multiple recent anecdotal reports and
informal surveys4–6 have implied a decline in the practice of resective surgery in the context
of TLE. Therefore, an accurate assessment of “perception” versus “reality” becomes critical
for multiple reasons ranging from prioritization of resource allocation to developing patient
management strategies.

Author Manuscript

The current mechanisms of formal large-scale data assessments for epilepsy surgery
practices and volumes are limited. In the United States, the often-used Nationwide Inpatient
Sample does not distinguish between temporal and extratemporal resections, so
differentiating practice patterns between the two surgery types is impossible.7 Self-reported
data from the National Association of Epilepsy Centers are challenging given variation both
in the type of centers included and the nature of information collected over time, as this
valuable database was designed for administrative goals rather than as a rigorous scientific
research tool.8,9 We present here a large-scale, comprehensive, and systematic survey
assessing epilepsy surgery practices across the last two decades at major epilepsy centers in
the United States, Europe, and Australia. The survey was intended to provide a valid and
objective measurement of the current state of epilepsy surgery to guide future practice and
research priorities.
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Methods
Patient population
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Ten individual comprehensive epilepsy centers with a long tradition in epilepsy surgery
participated in this survey. These included Cleveland Clinic, Mayo Clinic – Rochester, New
York University, Thomas Jefferson University/Graduate Hospital, Yale University,
University of Alabama – Birmingham, and University of California Los Angeles from the
United States; University of Bonn from Germany; and Austin Health & Royal Melbourne
Hospital, The University of Melbourne from Australia. Data from the latter two University
of Melbourne centers were combined into one “Melbourne Centre,” making a total of nine
participating epilepsy centers. These centers were selected because they have wellestablished comprehensive epilepsy surgery programs, with international reputations, and
maintain accurate prospective patient records on their epilepsy surgeries. Centers reviewed
their epilepsy surgery research databases for clinical, surgical, and imaging patient
characteristics for three milestone years (1991, 2001, and 2011). Only patients 12 years or
older were included. Data collected included age at surgery, gender, magnetic resonance
imaging (MRI) findings, histopathologic results, and the number and type of epilepsy
surgeries. Centers performed en bloc resections of the hippocampus throughout the duration
of the study. Overall, data collection was complete in all the surgical databases except for
Center 6, which did not collect information on histopathology.
Study variable definitions

Author Manuscript

MRI and histopathologic findings were classified as showing evidence of mesial temporal
sclerosis (MTS) versus not; clear other pathologies such as tumors, cortical malformations,
or not; any abnormalities versus completely normal. The types of surgery were categorized
into anteromedial temporal resections for m-TLE, neocortical temporal lobe resection,
temporal lobectomy-not specified (anterior temporal lobe resection [ATL]), amygdalohippocampectomy, extratemporal resections, hemispherectomy, corpus callosotomy, subpial
transection, multilobar resections, and invasive EEG evaluations without a subsequent
resection.
Statistical methods

Author Manuscript

Variables of interest including total numbers of all surgeries and total numbers of ATL and
proportions of m-TLE-related surgeries were described for 1991, 2001, and 2011.
Comparison of the change in total and MTS-related surgeries were performed using paired ttests. In addition to the three milestone dates, six study centers provided complete study data
for annual or bi-annual intervals spanning the study period (1991–2011), facilitating more
detailed trend analyses. These comprised Cleveland Clinic, Mayo Clinic, NYU, Thomas
Jefferson University, Yale, and Melbourne. Using this more detailed dataset, we performed
multivariate Poisson regression for MTS rates adjusting for center. The exposure for this
model was set as the total number of surgeries per center per year. All statistical analyses
were performed using Stata 13.1 (StataCorp, College Station, TX, U.S.A.).
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The nine study centers contributed 1,346 patients (mean 149 patients/center; standard
deviation of 77 patients; median 114 patients/center). Table 1 illustrates the main staffing
changes observed in the study centers between 1991 and 2011. In Figure 1, the variation in
the total number of epilepsy surgeries across the three milestone dates (A) is further detailed
into the variation in the total number of MTS-related surgeries (C) and the variation in the
number of surgery patients with nonlesional epilepsy (E). Overall, Figure 1 suggests a
reduction in the number of MTS-related surgeries between 1991 and 2011, and an increase
in the number of nonlesional surgical patients. In fact, when the practice of MTS-related
surgery was considered in detail (Fig. 2), five of the centers performed their highest number
of surgeries for mesial temporal sclerosis (MTS) in 1991, three had their highest number of
MTS surgeries in 2001, and only one center achieved its peak number of MTS surgeries in
2011. Although the most productive year for MTS surgeries varied then by center, overall,
the nine centers surveyed performed 48% (95% confidence interval [CI] −27.3% to −67.4%)
fewer such surgeries in 2011 compared to either 1991 or 2001, whichever was higher. There
was a corresponding trend toward reduction in total number of epilepsy surgeries in 2011
compared to the peak value, but this was less than the reduction in MTS surgeries (mean
change from peak year = −25.2%, 95% CI −49.2 to +1.0%, p = 0.1) The Poisson regression
demonstrated a significant reduction in the annual number of MTS cases per center over
time (decline of 0.58 cases/year; p < 0.001; Fig. 3). In addition, over the same time interval
in centers 1–5 (implant without resection data were unavailable from center 6), the
proportion of patients undergoing intracranial EEG implantation without subsequent
resection increased 3.3 fold: when adjusted for center, the increase was 0.7%/year, p < 0.001
(Fig. S1).
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In summary (Figs. 1–3), although MTS was the main surgical substrate in 1991 and 2001
(proportion of total resections was 42.6 ± 22.8% and 36.5 ± 12.4%, respectively), it
occupied only 30.5 ± 10.7% of all resections in 2011. Correspondingly, the mean proportion
of nonlesional cases increased from 22.0 ± 11.2% in 1991 to 33.1 ± 22.2% in 2011.

Discussion
The international effort presented here provides a longitudinal description of the evolution of
epilepsy surgery practices across the last two decades in nine selected major surgical
epilepsy centers across the United States, Germany, and Australia. Three main “evolutionary
processes” defining the current face of epilepsy surgery can be hypothesized:
1.

Author Manuscript

The practice of m-TLE surgery is decreasing in major surgical epilepsy
centers:
Potential explanations are the following:
a.

The practice of m-TLE-related surgery is actually not
decreasing: this is a purely artificial finding due to an
increasing number of extratemporal surgeries leading to a
relative drop in the proportion of all surgeries attributed to
m-TLE. The gradual concurrent reduction in the absolute
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numbers of m-TLE-related surgery (Fig. 1) performed in
our centers strongly argues against this possibility and
favors a true drop in practice. In fact, this drop in absolute
numbers is even more striking, considering that it
progressively decreased over time, even though each one
of these surgical centers was becoming more established
and gaining in reputation as a referral center.
The practice of m-TLE-related surgery is indeed
decreasing in major epilepsy centers, but this is merely a
reflection of varying referral patterns with “simpler” mTLE-related surgeries occurring in local hospitals instead.
This is a critical hypothesis to entertain given the sample
bias in our survey. The cohort reported here represents a
select group of likely the most complex epilepsy surgery
cases, evaluated in specialized centers, potentially
underrepresenting easily recognizable MTS cases operated
on locally in private practice groups or smaller academic
epilepsy programs. Barriers to care10,11 and disparities in
access to epilepsy surgery12,13 may restrict the choices of
patients with drug-resistant epilepsy or simply direct them
to obtain care locally. However, recent data from the
Nationwide Inpatient Sample demonstrated a gradual
overall national reduction in the practice of epilepsy
surgery within the United States, across all hospitals and
levels of care.7 This concerning overall reduction in
surgical numbers, the continuing long epilepsy duration
and high number of anticonvulsant trials prior to epilepsy
surgery10 emphasize the ever-urgent need for early
identification and referral of patients with drug-resistant
epilepsy for possible surgical evaluation. However, in our
study here we found the same pattern of reduced m-TLE
surgery in Bonn and in Australia, countries with different
healthcare systems and referral patterns. Such a ubiquitous
observation of a reduction in m-TLE–related surgeries
suggests that although a redistribution hypothesis is
possible, it is unlikely to be the only answer.

c.

The last hypothesis is that the practice of m-TLE-related
surgery is indeed decreasing because the epidemiology of
drug-resistant epilepsy is shifting, and there is now a
“smaller pool” of drug-resistant epilepsy patients with
hippocampal sclerosis as their epilepsy substrate. Under
this assumption, every geographic area’s local patients
with hippocampal sclerosis represent a prevalent pool that
is efficiently surgically treated by local surgical epilepsy

Author Manuscript
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center(s), but inefficiently replenished due to various
factors, including an insidious course of intractability,14–16
and better treatment of m-TLE risk factors such as
infections and complex febrile seizures with antiinflammatory medications.17–19 Additional evidence
supporting this hypothesis include recent data
demonstrating that in addition to a reduction in numbers of
MTS cases receiving surgery, the age at surgery is
increasing, suggesting a diminishing supply of younger
MTS cases.17
There is an increase in the practice of extratemporal resections,
particularly in the context of surgery for nonlesional epilepsy (Fig. 1E,F):
Potential drivers for this include better diagnostic techniques and
neuroimaging modalities facilitating localization of the epileptogenic zone
extratemporally,20–22 the improved noninvasive functional assessment
tools allowing better risk-adjustment such as diffusion tensor imaging for
mapping of visual and motor fibers,23 and the growing literature about
possible favorable seizure freedom outcomes for extratemporal lobe
surgery.24–33 It is interesting to observe that although this general trend
was true for the cohort as a whole, it was not observed uniformly across
centers (Fig. 1E), reflecting varying comfort levels and opinions about
appropriateness of surgery in this challenging patient population that may
obtain substantial benefit from early surgery.32

3.

The use of invasive EEG evaluations that do not lead to subsequent brain
resections is increasing (Fig. S1). Multiple potential explanations exist for
these findings in 6/9 centers. A growing experience with invasive EEG
implantations may have led to safer use of this technology and thus
reduced the “implantation threshold,” even in patients with an anticipated
suboptimal yield of epilepsy localization. Alternatively, as epileptologists
encounter a mounting plethora of imaging and electrophysiologic
techniques (ictal SPECT, PET, MEG, EEG-fMRI, etc.), it becomes easier
to find “concordance” between any given number of these tests and thus
formulate misleading localization hypotheses and subsequent unsuccessful
invasive evaluations. Regardless of its causes, this finding highlights a
very challenging situation. The decision to proceed directly to a resection
versus perform an invasive EEG evaluation to test an epilepsy localization
hypothesis versus to withhold surgery altogether is a very complex one:
the choice depends on multiple factors, including the epilepsy severity, the
risks of any neurological functional deficits with the anticipated brain
resection, and the expertise of the surgical center in performing different
invasive EEG techniques. Until better nonsurgical treatment options
become available, it remains critical to use all noninvasive and invasive
tools in our disposal to investigate the possibility of resective surgery. On
the other hand, given the significant risk of neurological complications and
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2.
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financial costs associated with such investigations, we need to learn how
to better target our presurgical testing and restrict invasive EEG
investigations to patients with a testable localization hypothesis.
Limitations

Author Manuscript
Author Manuscript

The heterogeneity of our findings is undeniable. Although a variable practice was most
obvious in relation to management of nonlesional drug-resistant epilepsy (Fig. 1E,F), there
was also demonstrable variation in the extent and rate of drop in the surgical MTS volumes
among centers and over time. There are likely multiple factors accounting for this beyond
the “availability” of MTS cases, including differences in timing of when individual surgical
centers were established, variations in staffing over time within a surgical center, disparities
in referral and reimbursement patterns, changes in the type and number of patients evaluated
for possible surgery, and evolving pre-surgical diagnostic tools. A newly established center
may find a prevalent pool of nonoperated MTS cases, and as it grows will increase its
activity. Moreover, the center may choose at any time to extend its reach in the absence of a
local pool of surgical patients. This variability in practice and variability in overall
presenting patient distribution over time is beyond our capability to quantify on a center by
center basis. But the overall trend is undeniable, particularly as it was observed DESPITE an
increase in the number of epileptologists and neurosurgeons between 1991 and 2011 in our
study centers (Table 1) and suggests that even as a center continues its activity over time,
eventually the number of MTS patients will decline. Such an idea is supported by
observations already reported in multiple healthcare systems, including on the national level
in the United States using the NIS database,7 in the United Kingdom where the number of
children receiving surgery for epilepsy had increased annually up to, and declined after, the
establishment of Children’s Epilepsy Surgery Service centers,34 and in Germany where an
epidemiological analysis of 2,812 patients who had TLE surgery between 1988 and 2008
showed an early increase in the proportion of patients with MTS during the first few years
studied, only to subsequently demonstrate an increase in the age and duration of epilepsy in
patients with MTS despite stable overall surgical numbers over time interpreted to suggest a
reduction in incidence of MTS.17
Implications of findings for future research

Author Manuscript

While debating the causes of our findings is important, it is critical to advance the discussion
further and tackle their implications. Making this leap is essential to develop the
“evolutionary” adaptive steps that would be necessary for the betterment of the care of
patients with drug-resistant epilepsy. Regardless of the cause, our data suggest that m-TLE
related surgeries no longer account for the major burden of surgical epilepsy in major
established epilepsy centers in the developed world, and an increasing number of patients
with complex nonlesional epilepsy are being assessed/undergoing surgery. As our patient
population is expanding in complexity, so should our clinical care resources and our research
priorities. Given our findings, specific suggestions for future research include:
1.

Thorough and systematic epidemiological research to better understand
and improve the utilization of epilepsy surgery, for ALL potential surgical
candidates. Such work will be critical to optimize the reach of epilepsy
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surgery for patients in “underserved” pockets with drug-resistant m-TLE,
and to enhance the identification of adequate surgical candidates among
the challenging group of nonlesional patients with drug-resistant focal
epilepsy.
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2.

Methodologically sound outcomes research to assess the effectiveness of
various surgical procedures and presurgical evaluation tools given the
observed heterogeneity among centers in their management of patients
with nonlesional drug resistant epilepsy. This variation together with the
increase in the number of invasive evaluations without subsequent
resections highlight a need to improve patient selection, presurgical
evaluation protocols, and outcomes of care in this complex surgical
population.

3.

Expanding the scope of clinical and basic science research studying extratemporal epilepsy given its growing contribution to the surgical epilepsy
burden. Continuing to predominantly focus various stakeholder resources
on m-TLE alone will fall short of addressing the present and future needs
of surgical epilepsy.

Conclusions

Author Manuscript

We cannot overemphasize the fact that it remains critical to reach pockets of “underserved”
epilepsy population in developed and developing countries with likely high prevalence of
hippocampal sclerosis. Understanding/solving the barriers to care remain paramount,
including the possibility that patient perception of disease severity and knowledge of
treatment options is little understood. In addition, our data suggest that we also owe a
significant effort to our patients with drug-resistant nonlesional epilepsy to better understand
their disease, localize it, resect it safely, grasp and improve the long-term success of surgery,
and even better, prevent the development of epilepsy. This will require major research
efforts, but our data suggest that these efforts would seem well-justified.

Supplementary Material
Refer to Web version on PubMed Central for supplementary material.

Biography

Author Manuscript

Dr. Lara Jehi is an adult epileptologist and the director of epilepsy research at Cleveland
Clinic.

Epilepsia. Author manuscript; available in PMC 2016 October 27.

Jehi et al.

Page 9

Author Manuscript

References

Author Manuscript
Author Manuscript
Author Manuscript

1. Wiebe S, Blume WT, Girvin JP, et al. A randomized, controlled trial of surgery for temporal-lobe
epilepsy. N Engl J Med. 2001; 345:311–318. [PubMed: 11484687]
2. Temporal Lobe Epilepsy. Epilepsy Foundation and Epilepsy Therapy Project. 2014. Available at:
http://www.epilepsy.com/learn/types-epilepsy-syndromes/temporal-lobe-epilepsy. Accessed
September 24, 2014
3. NINDS. Project Listing by Category. 2013. Available at: http://report.nih.gov/
categorical_spending_project_listing.aspx?FY=2013&ARRA=N&DCat=Epilepsy. Accessed
September 19, 2015
4. Carlson C. The changing face of epileptology? Results of the initial Q-PULSE survey. Epilepsy
Curr. 2013; 13:305–307. [PubMed: 24348135]
5. Neligan A, Haliasos N, Pettorini B, et al. A survey of adult and pediatric epilepsy surgery in the
United Kingdom. Epilepsia. 2013; 54:e62–e65. [PubMed: 23551079]
6. Kumlien E, Mattsson P. Attitudes towards epilepsy surgery: a nationwide survey among Swedish
neurologists. Seizure. 2010; 19:253–255. [PubMed: 20227303]
7. Englot DJ, Ouyang D, Garcia PA, et al. Epilepsy surgery trends in the United States, 1990–2008.
Neurology. 2012; 78:1200–1206. [PubMed: 22442428]
8. National Association of Epilepsy Center Homepage. 2007. Available at: http://www.naecepilepsy.org/. Accessed October 8, 2014
9. Labiner DM, Bagic AI, Herman ST, et al. Essential services, personnel, and facilities in specialized
epilepsy centers – revised 2010 guidelines. Epilepsia. 2010; 51:2322–2333. [PubMed: 20561026]
10. Bateman LM, Begley CE, Ben-Menachem E, et al. Overcoming barriers to successful epilepsy
management. Epilepsy Curr. 2012; 12:158–160. [PubMed: 22936891]
11. Erba G, Moja L, Beghi E, et al. Barriers toward epilepsy surgery. A survey among practicing
neurologists. Epilepsia. 2012; 53:35–43.
12. Betjemann JP, Thompson AC, Santos-Sanchez C, et al. Distinguishing language and race
disparities in epilepsy surgery. Epilepsy Behav. 2013; 28:444–449. [PubMed: 23891765]
13. Hrazdil C, Roberts JI, Wiebe S, et al. Patient perceptions and barriers to epilepsy surgery:
evaluation in a large health region. Epilepsy Behav. 2013; 28:52–65. [PubMed: 23660081]
14. Berg AT, Zelko FA, Levy SR, et al. Age at onset of epilepsy, pharmacoresistance, and cognitive
outcomes: a prospective cohort study. Neurology. 2012; 79:1384–1391. [PubMed: 22972641]
15. Berg AT, Mathern GW, Bronen RA, et al. Frequency, prognosis and surgical treatment of structural
abnormalities seen with magnetic resonance imaging in childhood epilepsy. Brain. 2009;
132:2785–2797. [PubMed: 19638447]
16. Berg AT. The natural history of mesial temporal lobe epilepsy. Curr Opin Neurol. 2008; 21:173–
178. [PubMed: 18317276]
17. Helmstaedter C, May TW, von Lehe M, et al. Temporal lobe surgery in Germany from 1988 to
2008: diverse trends in etiological subgroups. Eur J Neurol. 2014; 21:827–834. [PubMed:
24313982]
18. Choy M, Dube CM, Ehrengruber M, et al. Inflammatory processes, febrile seizures, and
subsequent epileptogenesis. Epilepsy Curr. 2014; 14:15–22. [PubMed: 24955071]
19. Dube CM, Ravizza T, Hamamura M, et al. Epileptogenesis provoked by prolonged experimental
febrile seizures: mechanisms and biomarkers. J Neurosci. 2010; 30:7484–7494. [PubMed:
20519523]
20. Sulc V, Stykel S, Hanson DP, et al. Statistical SPECT processing in MRI-negative epilepsy surgery.
Neurology. 2014; 82:932–939. [PubMed: 24532274]
21. Widjaja E, Li B, Medina LS. Diagnostic evaluation in patients with intractable epilepsy and normal
findings on MRI: a decision analysis and cost-effectiveness study. AJNR Am J Neuroradiol. 2013;
34:1004–1009. S1–2. [PubMed: 23391843]
22. Knowlton RC, Razdan SN, Limdi N, et al. Effect of epilepsy magnetic source imaging on
intracranial electrode placement. Ann Neurol. 2009; 65:716–723. [PubMed: 19557860]

Epilepsia. Author manuscript; available in PMC 2016 October 27.

Jehi et al.

Page 10

Author Manuscript
Author Manuscript

23. Piper RJ, Yoong MM, Kandasamy J, et al. Application of diffusion tensor imaging and
tractography of the optic radiation in anterior temporal lobe resection for epilepsy: a systematic
review. Clin Neurol Neurosurg. 2014; 124:59–65. [PubMed: 25016240]
24. Jeha LE, Najm I, Bingaman W, et al. Surgical outcome and prognostic factors of frontal lobe
epilepsy surgery. Brain. 2007; 130:574–584. [PubMed: 17209228]
25. Lazow SP, Thadani VM, Gilbert KL, et al. Outcome of frontal lobe epilepsy surgery. Epilepsia.
2012; 53:1746–1755. [PubMed: 22780836]
26. See SJ, Jehi LE, Vadera S, et al. Surgical outcomes in patients with extratemporal epilepsy and
subtle or normal magnetic resonance imaging findings. Neurosurgery. 2013; 73:68–77. [PubMed:
23615090]
27. Noe K, Sulc V, Wong-Kisiel L, et al. Long-term outcomes after nonlesional extratemporal lobe
epilepsy surgery. JAMA Neurol. 2013; 70:1003–1008. [PubMed: 23732844]
28. Ansari SF, Maher CO, Tubbs RS, et al. Surgery for extratemporal nonlesional epilepsy in children:
a meta-analysis. Childs Nerv Syst. 2010; 26:945–951. [PubMed: 20013124]
29. Ansari SF, Tubbs RS, Terry CL, et al. Surgery for extratemporal nonlesional epilepsy in adults: an
outcome meta-analysis. Acta Neurochir (Wien). 2010; 152:1299–1305. [PubMed: 20524016]
30. McGonigal A, Bartolomei F, Regis J, et al. Stereoelectroencephalography in presurgical
assessment of MRI-negative epilepsy. Brain. 2007; 130:3169–3183. [PubMed: 17855377]
31. Cossu M, Cardinale F, Colombo N, et al. Stereoelectroencephalography in the presurgical
evaluation of children with drug-resistant focal epilepsy. J Neurosurg. 2005; 103:333–343.
[PubMed: 16270685]
32. Simasathien T, Vadera S, Najm I, et al. Improved outcomes with earlier surgery for intractable
frontal lobe epilepsy. Ann Neurol. 2013; 73:646–654. [PubMed: 23494550]
33. Sarkis RA, Jehi L, Najm IM, et al. Seizure outcomes following multilobar epilepsy surgery.
Epilepsia. 2012; 53:44–50. [PubMed: 21955142]
34. Shastin D, Chandrasekaran S, Ferrie C, et al. Monitoring the changing pattern of delivery of
paediatric epilepsy surgery in England-an audit of a regional service and examination of national
trends. Childs Nerv Syst. 2015; 31:931–939. [PubMed: 25896219]

Author Manuscript
Author Manuscript
Epilepsia. Author manuscript; available in PMC 2016 October 27.

Jehi et al.

Page 11

Author Manuscript

Key Points
•

The practice of surgery for mesial temporal lobe epilepsy is decreasing
in major surgical epilepsy centers

•

There is an increase in the practice of extratemporal resections,
particularly in the context of surgery for nonlesional epilepsy

•

The use of invasive EEG evaluations that do not lead to subsequent
brain resections is increasing
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Figure 1.
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Number of epilepsy surgeries reported in 1991, 2001, and 2011 for nine epilepsy centers.
(A) Total epilepsy surgeries at each time point for individual epilepsy centers. Two centers
(3 and 7) were not active or did not track statistics in 1991. (B) Sum of all epilepsy surgeries
across the nine epilepsy centers for each time point. The overall number of epilepsy
surgeries at these nine centers does not exhibit consistent trends. Some centers (2, 6, and 7)
reported overall increases in total surgeries whereas others reported declines. (C) Number of
MTS-related surgeries at each time point for individual centers. All but one center (7)
reported a decline in MTS-related surgeries in 2011 compared to a prior peak in either 1991
or 2001. (D) Sum of all MTS-related surgeries across the nine centers. Overall, there was a
decline in total MTS-related resections in the group. (E) Number of surgeries performed for
nonlesional epilepsy (NL) at each time point for individual centers. Five of the nine centers
reported an increase in the number of surgeries performed for NL epilepsy in 2011
compared to prior years. (F) Sum of all NL epilepsy–related resections across the nine
centers. Overall, there was an increase in the number of NL epilepsy–related surgeries in
2011.
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Figure 2.
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Plot of the percent change in total and MTS-related surgeries at each center compared to the
peak number of surgeries (the highest value reported in the prior two time points, 1991 or
2001). All but one center reported a decline in MTS-related surgeries in 2011 compared to
the prior peaks. The mean change was 48.0% (95% CI −27.3 to −67.4%, blue line).
Although most centers also reported a decline in epilepsy surgeries overall, this change was
less pronounced (mean change −25.6%, 95% CI −51.0 to +1.0%, black line) and two centers
reported an overall increase.
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Number of epilepsy surgeries per year for five centers that provided annual or biannual data
from 1991 to 2011. When adjusted for center, there was an overall reduction of 0.34 MTSrelated surgeries per year (dashed line) across the two decades. This translates into a 1.3%
reduction in MTS-related surgeries annually compared to 1991.
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